Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 Aug;27(8):934–941. doi: 10.1136/gut.27.8.934

HLA-A and -B antigens in inflammatory bowel disease.

I Biemond, W R Burnham, J D'Amaro, M J Langman
PMCID: PMC1433367  PMID: 3460939

Abstract

We examined all available data on HLA-A and -B antigen distributions in patients with Crohn's disease and ulcerative colitis. The risk of Crohn's disease was significantly increased in individuals with HLA-A2, having a relative risk of 1.25, in 730 pooled Caucasoid patients compared with 10 863 pooled controls, and decreased in individuals with HLA-A11, having a relative risk of 0.62. The risk of ulcerative colitis was also significantly increased in individuals with HLA-B27 and -Bw35, having a relative risk of 1.81 and 1.41 respectively, in 560 pooled Caucasoid patients compared with 6151 pooled controls, whilst in 144 pooled Japanese patients who were compared with 442 pooled controls, the risk of colitis was increased in individuals with HLA-B5 with a relative risk of 2.79. All differences remained significant after correction for the number of antigens examined. The bases for these genetic associations are unclear.

Full text

PDF
939

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asakura H., Tsuchiya M., Aiso S., Watanabe M., Kobayashi K., Hibi T., Ando K., Takata H., Sekiguchi S. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology. 1982 Mar;82(3):413–418. [PubMed] [Google Scholar]
  2. Bergman L., Lindblom J. B., Säfwenberg J., Krause U. HL-A frequencies in Crohn's disease and ulcerative colitis. Tissue Antigens. 1976 Mar;7(3):145–150. doi: 10.1111/j.1399-0039.1976.tb01044.x. [DOI] [PubMed] [Google Scholar]
  3. Bodmer J. G., Bodmer W. F., Pickbourne P., Degos L., Dausset J., Dick H. M. Combined analysis of three studies of patients with Burkitt's lymphoma. Tissue Antigens. 1975 Feb;5(1):63–68. doi: 10.1111/j.1399-0039.1975.tb00529.x. [DOI] [PubMed] [Google Scholar]
  4. Delpre G., Kadish U., Gazit E., Joshua H., Zamir R. HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology. 1980 Jun;78(6):1452–1457. [PubMed] [Google Scholar]
  5. Eade O. E., Moulton C., MacPherson B. R., Andre-Ukena S. S., Albertini R. J., Beeken W. L. Discordant HLA haplotype segregation in familial Crohn's disease. Gastroenterology. 1980 Aug;79(2):271–275. [PubMed] [Google Scholar]
  6. Gleeson M. H., Walker J. S., Wentzel J., Chapman J. A., Harris R. Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut. 1972 Jun;13(6):438–440. doi: 10.1136/gut.13.6.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HALDANE J. B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet. 1956 May;20(4):309–311. doi: 10.1111/j.1469-1809.1955.tb01285.x. [DOI] [PubMed] [Google Scholar]
  8. Hiwatashi N., Kikuchi T., Masamune O., Ouchi E., Watanabe H., Goto Y. HLA antigens in inflammatory bowel disease. Tohoku J Exp Med. 1980 Aug;131(4):381–385. doi: 10.1620/tjem.131.381. [DOI] [PubMed] [Google Scholar]
  9. Mallas E. G., Mackintosh P., Asquith P., Cooke W. T. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). Gut. 1976 Nov;17(11):906–910. doi: 10.1136/gut.17.11.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miettinen O. S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974 May;99(5):325–332. doi: 10.1093/oxfordjournals.aje.a121617. [DOI] [PubMed] [Google Scholar]
  11. Nahir M., Gideoni O., Eidelman S., Barzilai A. Letter: HLA antigens in ulcerative colitis. Lancet. 1976 Sep 11;2(7985):573–573. doi: 10.1016/s0140-6736(76)91820-1. [DOI] [PubMed] [Google Scholar]
  12. Peña A. S., Biemond I., Kuiper G., Weterman I. T., van Leeuwen A., Schreuder I., van Rood J. J. HLA antigen distribution and HLA haplotype segregation in Crohn's disease. Tissue Antigens. 1980 Jul;16(1):56–61. doi: 10.1111/j.1399-0039.1980.tb00287.x. [DOI] [PubMed] [Google Scholar]
  13. Russell A. S., Percy J. S., Schlaut J., Sartor V. E., Goodhart J. M., Sherbaniuk R. W., Kidd E. G. Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis. 1975 Apr;20(4):359–361. doi: 10.1007/BF01237793. [DOI] [PubMed] [Google Scholar]
  14. Smolen J. S., Gangl A., Polterauer P., Menzel E. J., Mayr W. R. HLA antigens in inflammatory bowel disease. Gastroenterology. 1982 Jan;82(1):34–38. [PubMed] [Google Scholar]
  15. Svejgaard A., Jersild C., Nielsen L. S., Bodmer W. F. HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens. 1974;4(2):95–105. doi: 10.1111/j.1399-0039.1974.tb00230.x. [DOI] [PubMed] [Google Scholar]
  16. Tsuchiya M., Yoshida T., Asakura H., Hibi T., Ono A. HLA antigens and ulcerative colitis in Japan. Digestion. 1977;15(4):286–294. doi: 10.1159/000198014. [DOI] [PubMed] [Google Scholar]
  17. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  18. Wiener A. S. Controversy in human genetics. Blood groups and disease. Am J Hum Genet. 1970 Jul;22(4):476–483. [PMC free article] [PubMed] [Google Scholar]
  19. Woodrow J. C., Lewkonia R. M., McConnell R. B., Berg-Loonen E. M., Meuwissen S. G., Dekker-Saeys B. J., Nijenhuis L. E., Mowbray J. F., Johnson N. M. HLA antigens in inflammatory bowel disease. Tissue Antigens. 1978 Feb;11(2):147–152. doi: 10.1111/j.1399-0039.1978.tb01240.x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES